by Ethan A. Huff, Natural News
American waistlines are apparently becoming too large for conventional cancer therapy, which means poison doses need to increase in order to achieve the same treatment outcomes. This is according to a new study recently published in the American Society of Clinical Oncology’s (ASCO) Journal of Clinical Oncology, which recommends that the guidelines for treating obese adult cancer patients be expanded to allow for the administration of higher doses of toxic chemotherapy.
As reported by USA Today, researchers from the country’s largest organization of doctors who treat cancer are adamantly pushing for more chemotherapy to treat those whom they claim are “under-treated,” mainly larger individuals who do not meet the standard dosage criteria for chemotherapy. According to their assessment, the survival rate among obese cancer patients is lower than it is among the standard weight population, a direct result of not receiving enough chemotherapy, they claim.
Please follow SGT Report on Twitter & help share the message.